Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4523 On Other Exchanges
Symbol
Exchange
4523 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Hideki Hayashi

Chief Information Officer and Representative Corporate Officer of Corporate Planning & Strategy,Eisai Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

58--

Background*

Mr. Hideki Hayashi serves as Chief Information Officer and Representative Corporate Officer of Corporate Planning & Strategy at Eisai Co., Ltd., and served as its Chief Product Creation Officer of Eisai Product Creation Systems and Representative Corporate Officer. Mr. Hayashi served as a Deputy President and Chief Product Creation Officer of Eisai Product Creation Systems for Global BD - Chief Executive Officer's special mission at Eisai Co. Ltd. Mr. Hayashi served ...

Read Full Background

Corporate Headquarters*

4-6-10, Koishikawa
Tokyo, -- 112-8088

Japan

Phone: 81 3 3817 3700
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4523:JP ¥6,864.00 JPY -520.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Howard W. Robin Chief Executive Officer, President and Director
Nektar Therapeutics
$860.0K
Howard Bradley Schiller Interim Chief Executive Officer and Director
Valeant Pharmaceuticals International, Inc.
$953.8K
Flemming Ornskov M.D., MBA, MPHChief Executive Officer, Managing Director and Director
Shire plc
$3.6M
Akira Kurokawa Chief Executive Officer, President, Director, Member of Nominating Committee, Member of Executive Compensation Committee and Member of Corporate Strategy Committee
Santen Pharmaceutical Co. Ltd.
¥90.0M
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Chief Executive of Corporate Development & Finance, Executive Director, Member of Management Board and Member of Compliance Committee
Almirall, S.A.
€1.1M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact EISAI CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.